These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 1963697

  • 1. Progesterone receptor antagonists and prostaglandins in human fertility regulation: a clinical review.
    Healy DL.
    Reprod Fertil Dev; 1990; 2(5):477-90. PubMed ID: 1963697
    [Abstract] [Full Text] [Related]

  • 2. Mifepristone (RU486) alone or in combination with a prostaglandin analogue for termination of early pregnancy: a review.
    Avrech OM, Golan A, Weinraub Z, Bukovsky I, Caspi E.
    Fertil Steril; 1991 Sep; 56(3):385-93. PubMed ID: 1894013
    [Abstract] [Full Text] [Related]

  • 3. Anti-progesterones for the interruption of pregnancy.
    Bygdeman M, Van Look PF.
    Baillieres Clin Obstet Gynaecol; 1988 Sep; 2(3):617-29. PubMed ID: 3069265
    [Abstract] [Full Text] [Related]

  • 4. A novel approach to human fertility control: contragestion by the anti-progesterone RU 486.
    Baulieu EE.
    Eur J Obstet Gynecol Reprod Biol; 1988 Jun; 28(2):125-9. PubMed ID: 3402651
    [Abstract] [Full Text] [Related]

  • 5. Antigestogens.
    Baird DT.
    Br Med Bull; 1993 Jan; 49(1):73-87. PubMed ID: 8324617
    [Abstract] [Full Text] [Related]

  • 6. Prostaglandins and progesterone receptor antagonists in human fertility regulation.
    Healy DL.
    Aust N Z J Obstet Gynaecol; 1994 Jun; 34(3):357-60. PubMed ID: 7848216
    [Abstract] [Full Text] [Related]

  • 7. Early pregnancy termination with antiprogestins: a comparative clinical study of RU 486 given in two dose regimens and Epostane.
    Birgerson L, Odlind V.
    Fertil Steril; 1987 Oct; 48(4):565-70. PubMed ID: 3653415
    [Abstract] [Full Text] [Related]

  • 8. Mode of action of RU 486.
    Bygdeman M, Swahn ML, Gemzell-Danielsson K, Svalander P.
    Ann Med; 1993 Feb; 25(1):61-4. PubMed ID: 8435191
    [Abstract] [Full Text] [Related]

  • 9. Fertility control in women: results with RU 486 by the end of 1985.
    Baulieu E.
    J Steroid Biochem; 1986 Nov; 25(5B):847-51. PubMed ID: 3807366
    [Abstract] [Full Text] [Related]

  • 10. The use of anti-progesterones as a medical IUD.
    Nieman LK, Loriaux DL.
    Baillieres Clin Obstet Gynaecol; 1988 Sep; 2(3):609-16. PubMed ID: 3233821
    [Abstract] [Full Text] [Related]

  • 11. Antiprogestins: mechanism of action and contraceptive potential.
    Spitz IM, Croxatto HB, Robbins A.
    Annu Rev Pharmacol Toxicol; 1996 Sep; 36():47-81. PubMed ID: 8725382
    [Abstract] [Full Text] [Related]

  • 12. Termination of early pregnancy by a single dose of mifepristone (RU 486), a progesterone antagonist.
    Maria B, Stampf F, Goepp A, Ulmann A.
    Eur J Obstet Gynecol Reprod Biol; 1988 Jul; 28(3):249-55. PubMed ID: 3208966
    [Abstract] [Full Text] [Related]

  • 13. The antiprogesterone steroid RU 486: a short pharmacological and clinical review, with emphasis on the interruption of pregnancy.
    Garfield RE, Baulieu EE.
    Baillieres Clin Endocrinol Metab; 1987 Feb; 1(1):207-21. PubMed ID: 3297023
    [Abstract] [Full Text] [Related]

  • 14. Antifertility actions of the progesterone antagonist RU 486 include direct inhibition of placental hormone secretion.
    Das C, Catt KJ.
    Lancet; 1987 Sep 12; 2(8559):599-601. PubMed ID: 2887889
    [Abstract] [Full Text] [Related]

  • 15. Progesterone antagonists on the horizon.
    Spitz IM, Bardin CW.
    Clin Obstet Gynecol; 1989 Jun 12; 32(2):403-13. PubMed ID: 2663280
    [Abstract] [Full Text] [Related]

  • 16. Mifegyne (mifepristone), a new antiprogestagen with potential therapeutic use in human fertility control.
    Couzinet B, Schaison G.
    Drugs; 1988 Mar 12; 35(3):187-91. PubMed ID: 3286211
    [Abstract] [Full Text] [Related]

  • 17. Steroid antagonists and receptor-associated proteins.
    Lebeau MC, Baulieu EE.
    Hum Reprod; 1994 Mar 12; 9(3):437-44. PubMed ID: 8006131
    [Abstract] [Full Text] [Related]

  • 18. RU486 (mifepristone): mechanisms of action and clinical uses.
    Cadepond F, Ulmann A, Baulieu EE.
    Annu Rev Med; 1997 Mar 12; 48():129-56. PubMed ID: 9046951
    [Abstract] [Full Text] [Related]

  • 19. [Clinical use of RU 486: control of the menstrual cycle and effect on the hypophyseal-adrenal axis].
    Gaillard RC, Herrmann W.
    Ann Endocrinol (Paris); 1983 Mar 12; 44(5):345-6. PubMed ID: 6675522
    [Abstract] [Full Text] [Related]

  • 20. Mifepristone (RU 486) for induced abortion.
    Grimes DA.
    Womens Health Issues; 1993 Mar 12; 3(3):171-5. PubMed ID: 8274873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.